1 / 9

Percutaneous CT-Guided Cryotherapy of Renal Masses: Long-term Follow-up and Morbidity.

Percutaneous CT-Guided Cryotherapy of Renal Masses: Long-term Follow-up and Morbidity. Hussein D. Aoun, M.D Wayne State University / Detroit Medical Center Department of Radiology Peter J. Littrup, M.D. Professor of Radiology. Urology & Radiation Oncology:

olinda
Download Presentation

Percutaneous CT-Guided Cryotherapy of Renal Masses: Long-term Follow-up and Morbidity.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Percutaneous CT-Guided Cryotherapy of Renal Masses: Long-term Follow-up and Morbidity. Hussein D. Aoun, M.D Wayne State University / Detroit Medical Center Department of Radiology Peter J. Littrup, M.D. Professor of Radiology. Urology & Radiation Oncology: Wayne State University/ Karmanos Cancer Institute

  2. Why ICE? • Cryotherapy = ‘Freezing’ needles accurately placed and monitored to sculpt treatment zone. • Cryo: • Historical established: 7-yr. prostate data – it works with low morbidity! • Painless with minimal sedation. • CT visible ice. • Preservation of collagenous architecture ~ healing potential…

  3. Cryotherapy Technology Transition: Laparotomy to Percutaneous

  4. Percutaneous Freeze Planning 0oVisible Margin by CT/US/MRI ~2.5 cm ~4.5 cm Isotherms, tissue types and heat loadare important for necrosis -150o ~ Probe surface temp -20o ~ Lethal for ‘watery’ tumors ~ 4 mm inside ice -40o ~ Lethal for fibrous tumors ~ 8 mm inside ice

  5. Renal Cryotherapy: 3/2008Methods & Materials:100 masses,90 patientsin 98 procedures • 23 Saline & 4 balloons – Bowel Protection • All outpatients – low pain during/after • Complications - 3% CTCAE grade > 3 • Mean F/U: 1.3 yrs; 47 >12mo; up to 5 yrs. • Recurrences – 4% - all early; probe fail/VHL

  6. Con-Arterial Average Tumor Size: 3.1cm {1.2-7.6}Average Ice Ball Size: 5.5 cm {3.1-9.7}

  7. Ablation Zone Follow-up: Size • CT/MR (-, +, delay) - 1, 3, 6, 12, 18, 24 months

  8. Renal Cryotherapy: KCI Results: Local Recurrences • 6% (6/100) of masses • 7% (6/90) of patients - 4 early experience (1st case undertreat near bowel, 1 probe failure and 2 image only - Bx neg & no progress) - 2 multi-focal tumor recur (VHL, pap Rca)

  9. Perc. Renal Cryotherapy Conclusions: • Minimal Pain –Outpatient Procedure! • Excellent Visualization of ICE under CT! • Balloon / Saline protection - adjacent organs! • Any location in the Kidney with good healing! • CURATIVE MINIMALLY INVASIVE TREATMENT OPTION FOR KIDNEY TUMORS!!!

More Related